EX-FILING FEES 4 tm2420729d1_ex-filingfees.htm EX-FILING FEES

 

Exhibit 107

 

Calculation of Filing Fee Tables

 

Form S-8
(Form Type)

 

Standard BioTools Inc.
(Exact Name of Registrant as Specified in its Charter)

 

Table 1: Newly Registered Securities

 

Security
Type

Security
Class
Title

Fee
Calculation
Rule

Amount
Registered

Proposed
Maximum
Offering
Price
Per Unit

Maximum
Aggregate
Offering Price

Fee
Rate

Amount of
Registration
Fee

Equity Common Stock $0.001 par value per share 457(c) and 457(h) 19,125,000(1) $1.53(2) $29,261,250 $0.00014760 $4,318.97
Total Offering Amounts $29,261,250   $4,318.97
Total Fees Previously Paid    
Total Fee Offsets    
Net Fee Due     $4,318.97

 

(1)The number of shares of common stock, par value $0.001 per share (“Common Stock”), of Standard BioTools Inc. (the “Registrant”) stated above consists of additional shares of Common Stock available for issuance pursuant to the Standard BioTools Inc. Amended and Restated 2011 Equity Incentive Plan, As Amended (the “2011 Plan”). In addition, pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement shall also cover any additional shares of the Registrant’s Common Stock that become issuable under the 2011 Plan by reason of an event such as any stock split, stock dividend or similar adjustment effected without the Registrant’s receipt of consideration that increases the number of the outstanding shares of Common Stock.

 

(2)Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(c) and Rule 457(h) under the Securities Act. The offering price per share and the aggregate offering price for shares reserved for future grant or issuance under the 2011 Plan are based upon a price of $1.53 per share, which is the average of the high and the low price of Registrant’s Common Stock as reported on The Nasdaq Global Select Market as of a date (August 1, 2024) within five business days prior to filing this Registration Statement.